In January, the University Hospital of Rennes in France released a statement indicating that one person had died and five others were hospitalized following a drug trial. In the weeks that have followed, it has been discovered that the drug being tested was designed to block necessary processes in the human Endocannabinoid Signaling (ECS) system. […]